psilocybin has been researched along with niacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tullis, P | 1 |
| Bradley, E; Brown, C; Brown, RT; Davis, MC; Dunlop, BW; Gapasin, T; Griffiths, RR; Gukasyan, N; Hassman, M; Heinzerling, K; Hu, X; Hutson, PR; Kakar, R; Kelly, DF; Kelmendi, B; Lenoch, K; Linton, W; Mletzko, T; Nayak, SM; Nelson-Douthit, C; Nicholas, CR; O'Donnell, KC; Penn, AD; Raison, CL; Robison, R; Ross, S; Sanacora, G; Sloshower, J; Tarpley, G; Trivedi, RP; Utzinger, M; Warchol, K; Wilson, S; Woolley, J | 1 |
2 other study(ies) available for psilocybin and niacin
| Article | Year |
|---|---|
How ecstasy and psilocybin are shaking up psychiatry.
Topics: Animals; Certification; Clinical Trials as Topic; Depression; Depressive Disorder, Treatment-Resistant; Drug Prescriptions; Efficiency; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Neuronal Plasticity; Niacin; Psilocybin; Psychiatry; Psychotherapy; Rumination, Cognitive; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic | 2021 |
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
Topics: Adult; Depressive Disorder, Major; Female; Hallucinogens; Humans; Male; Mental Health; Niacin; Psilocybin | 2023 |